TY  - GEN
AU  - Landau,H
AU  - Hassoun,H
AU  - Rosenzweig,M A
AU  - Maurer,M
AU  - Liu,J
AU  - Flombaum,C
AU  - Bello,C
AU  - Hoover,E
AU  - Riedel,E
AU  - Giralt,S
AU  - Comenzo,R L
TI  - Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
SN  - 1476-5551
PY  - 2013///0604
KW  - Adult
KW  - Aged
KW  - Amyloidosis
KW  - drug therapy
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Boronic Acids
KW  - administration & dosage
KW  - Bortezomib
KW  - Dexamethasone
KW  - Female
KW  - Humans
KW  - Male
KW  - Melphalan
KW  - Middle Aged
KW  - Pyrazines
KW  - Stem Cell Transplantation
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2012.274
ER  -